KR102353262B1 - 펩티드 생산용 융합 파트너 - Google Patents

펩티드 생산용 융합 파트너 Download PDF

Info

Publication number
KR102353262B1
KR102353262B1 KR1020177017007A KR20177017007A KR102353262B1 KR 102353262 B1 KR102353262 B1 KR 102353262B1 KR 1020177017007 A KR1020177017007 A KR 1020177017007A KR 20177017007 A KR20177017007 A KR 20177017007A KR 102353262 B1 KR102353262 B1 KR 102353262B1
Authority
KR
South Korea
Prior art keywords
seq
protein
fusion protein
kda
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177017007A
Other languages
English (en)
Korean (ko)
Other versions
KR20170085129A (ko
Inventor
다이앤 엠 리탈랙
아담 채프먼
토르벤 알 브럭
홍판 진
Original Assignee
피페넥스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피페넥스 인크. filed Critical 피페넥스 인크.
Publication of KR20170085129A publication Critical patent/KR20170085129A/ko
Application granted granted Critical
Publication of KR102353262B1 publication Critical patent/KR102353262B1/ko
Assigned to 펠리칸 테크놀로지 홀딩스, 인크. reassignment 펠리칸 테크놀로지 홀딩스, 인크. 권리의 전부이전등록 Assignors: 피페넥스 인크.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21009—Enteropeptidase (3.4.21.9), i.e. enterokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020177017007A 2014-12-01 2015-11-30 펩티드 생산용 융합 파트너 Active KR102353262B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462086119P 2014-12-01 2014-12-01
US62/086,119 2014-12-01
PCT/US2015/063027 WO2016089782A1 (en) 2014-12-01 2015-11-30 Fusion partners for peptide production

Publications (2)

Publication Number Publication Date
KR20170085129A KR20170085129A (ko) 2017-07-21
KR102353262B1 true KR102353262B1 (ko) 2022-01-18

Family

ID=56092296

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177017007A Active KR102353262B1 (ko) 2014-12-01 2015-11-30 펩티드 생산용 융합 파트너

Country Status (16)

Country Link
US (2) US10118956B2 (https=)
EP (1) EP3227455B1 (https=)
JP (2) JP6817939B2 (https=)
KR (1) KR102353262B1 (https=)
CN (2) CN107532190B (https=)
AR (1) AR102865A1 (https=)
AU (1) AU2015355242B2 (https=)
CA (1) CA2966358C (https=)
DK (1) DK3227455T3 (https=)
ES (1) ES2952405T3 (https=)
MX (1) MX386884B (https=)
NZ (1) NZ732400A (https=)
RU (1) RU2017123283A (https=)
SG (1) SG11201704362VA (https=)
TW (1) TWI702289B (https=)
WO (1) WO2016089782A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク． ペプチド産生のための融合パートナー
US9798758B2 (en) 2015-05-15 2017-10-24 Foogal Incorporated Food freshness notification from personal food inventory
JP7784804B2 (ja) 2017-10-27 2025-12-12 フェネックス インク． 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法
WO2019083794A1 (en) 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
US11267863B2 (en) 2018-01-19 2022-03-08 Pepgene Inc. N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
CN108191981B (zh) * 2018-02-06 2020-11-03 美药星（南京）制药有限公司 一种利拉鲁肽中间体多肽的制备方法
KR102009709B1 (ko) * 2018-02-14 2019-08-12 주식회사 펩진 융합 폴리펩타이드를 이용하여 인간 부갑상선 호르몬 1-84를 생산하는 방법
KR102017542B1 (ko) * 2018-02-14 2019-09-03 주식회사 펩진 융합 폴리펩타이드를 이용하여 글루카곤 유사 펩타이드-2 또는 이의 유사체를 생산하는 방법
KR102017540B1 (ko) * 2018-02-14 2019-09-03 주식회사 펩진 융합 폴리펩타이드를 이용하여 글루카곤 유사 펩타이드-1 또는 이의 유사체를 생산하는 방법
CN108977423A (zh) * 2018-08-17 2018-12-11 集美大学 一种从猪肺中分离提纯血管紧张素转化酶的方法
KR102011291B1 (ko) * 2018-12-05 2019-10-21 주식회사 펩진 신규한 융합 폴리펩타이드 및 이를 이용하여 인간 부갑상선 호르몬 1-34를 생산하는 방법
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN110305223B (zh) * 2019-06-26 2022-05-13 重庆派金生物科技有限公司 重组串联融合蛋白制备目标多肽的方法
KR20210010368A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 글루카곤 유사 펩타이드-2 또는 이의 유사체 생산용 융합태그
KR20210010367A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 인간부갑상선호르몬1-34 생산용 융합태그
KR20210010366A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 글루카곤 유사 펩타이드-1 또는 이의 유사체 생산용 융합태그
WO2021091304A1 (ko) * 2019-11-08 2021-05-14 한국해양과학기술원 신규한 인간 상피세포성장인자-tf 융합 단백질 및 이의 용도
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
WO2022016118A2 (en) * 2020-07-17 2022-01-20 Cb Therapeutics, Inc. Prenyltransferase enzymes
CN113151296B (zh) * 2021-03-22 2022-09-13 云南中烟工业有限责任公司 一种烟草热激蛋白相关的基因及其应用
CN112941058B (zh) * 2021-04-02 2023-12-05 重庆科润生物医药研发有限公司 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用
CN113025599B (zh) * 2021-04-02 2023-09-12 重庆科润生物医药研发有限公司 一种重组溶组织梭菌i型胶原酶及其制备方法和应用
KR20240021234A (ko) * 2021-06-10 2024-02-16 펠리칸 테크놀로지 홀딩스, 인크. 재조합 단백질 발현을 위한 박테리아 숙주
EP4380955A1 (en) * 2021-08-06 2024-06-12 Roche Diagnostics GmbH Chimeric igg-fc-binding ligand polypeptide and uses thereof for igg affinity purification
WO2023049631A2 (en) * 2021-09-09 2023-03-30 Northwestern University Cell-free methods and compositions comprising tagless therapeutic hormones
CN114350587B (zh) * 2022-01-24 2023-10-31 修实生物医药(南通)有限公司 一种基因重组串联表达利那洛肽的工程菌
CN115109766A (zh) * 2022-02-14 2022-09-27 上海理工大学 一种耐高温金属蛋白酶及其编码基因和应用
WO2024035782A1 (en) * 2022-08-10 2024-02-15 Aav Gene Therapeutics, Inc. Aav-mediated intramuscular delivery of insulin
WO2025081111A1 (en) * 2023-10-12 2025-04-17 The University Of Chicago Methods and compositions for characterizing rna-binding protein binding sites by in-situ reverse transcription-based sequencing
CN121405791A (zh) * 2025-12-26 2026-01-27 中国极地研究中心(中国极地研究所) 一种重组胶原蛋白三螺旋折叠与稳定化方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
US7150974B1 (en) 1991-04-05 2006-12-19 The General Hospital Corporation Parathyroid hormone receptor binding method
WO1993006217A1 (en) 1991-09-19 1993-04-01 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
CA2125467C (en) 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
US5935824A (en) 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
CA2198966C (en) 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
JPH1175879A (ja) * 1997-07-08 1999-03-23 Toyota Central Res & Dev Lab Inc プロテインジスルフィドイソメラーゼを含有する融合タンパク質をコードするｄｎａ
US5989868A (en) 1997-09-12 1999-11-23 The Board Of Regents Of The University Of Oklahoma Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli
DE69937272T2 (de) 1998-01-30 2008-07-10 Asubio Pharma Co., Ltd. Verfahren zur herstellung eines peptids mittels eines hilfspeptids
US6242219B1 (en) 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
WO2001098366A2 (en) 2000-06-19 2001-12-27 Dyax Corp. Enterokinase cleavage sequences and their use
JP2002262873A (ja) 2001-03-06 2002-09-17 Inst Of Physical & Chemical Res タンパク質ドメインの製造方法及びその方法により得られたドメインを用いるタンパク質の立体構造解析方法
DK1402015T3 (da) * 2001-06-22 2011-12-05 Hoffmann La Roche Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein og FkpA eller SlyD
CN100427506C (zh) 2001-07-26 2008-10-22 高级蛋白质技术公司 从融合多肽制备感兴趣的多肽的方法
AU2003256365B2 (en) 2002-07-03 2010-02-18 Pfenex Inc. Benzoate- and anthranilate-inducible promoters
US7390639B2 (en) 2002-08-09 2008-06-24 National Research Council Of Canada Staphylococcal nuclease fusion proteins for the production of recombinant peptides
US7208585B2 (en) 2002-09-18 2007-04-24 Genencor International, Inc. Protein purification
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
WO2004092221A1 (ja) 2003-04-18 2004-10-28 Sekisui Chemical Co. Ltd. 免疫原及び免疫用組成物、並びにそれらを使用する抗体の製造方法
JP2005110591A (ja) 2003-10-08 2005-04-28 Sekisui Chem Co Ltd 蛋白質の分離方法
CA2545610C (en) 2003-11-19 2014-03-25 Dow Global Technolgies Inc. Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression
AU2004317306B2 (en) 2003-11-21 2010-09-02 Pelican Technology Holdings, Inc. Improved expression systems with Sec-system secretion
JP2007512008A (ja) 2003-11-24 2007-05-17 ノボ　ノルディスク　アクティーゼルスカブ 融合タンパク質及び該タンパク質の切断方法
ES2663594T3 (es) * 2004-01-16 2018-04-16 Pfenex Inc Expresión de proteínas de mamífero en Pseudomonas fluorescens
WO2006078273A2 (en) 2004-04-26 2006-07-27 The United States Of America As Represented By Teh Secretary Of Health And Human Services, Nih Methods and compositions for producing recombinant proteins
JP4988337B2 (ja) 2004-05-21 2012-08-01 タカラバイオ株式会社 ポリペプチドの製造方法
US8603824B2 (en) 2004-07-26 2013-12-10 Pfenex, Inc. Process for improved protein expression by strain engineering
ATE540981T1 (de) 2004-08-11 2012-01-15 Univ Ramot Lösliche fusionsproteine enthaltend heterologe polypeptide
EP1871785B1 (en) 2005-04-20 2010-05-05 Viromed Co., Ltd Compositions and methods for fusion protein separation
PL1888763T3 (pl) 2005-06-06 2015-12-31 Pfenex Inc Systemy promotorowe indukowane mannitolem w bakteryjnych komórkach gospodarza
EP2021489A2 (en) 2006-05-30 2009-02-11 Dow Global Technologies Inc. Codon optimization method
WO2008027099A2 (en) 2006-05-30 2008-03-06 Dow Global Technologies Inc. Rpa optimization
EP1873251A1 (en) * 2006-06-29 2008-01-02 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells
JP5714230B2 (ja) 2007-01-31 2015-05-07 フェネックス インコーポレイテッド 発現上昇のための細菌リーダー配列
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (ja) * 2007-04-27 2014-03-19 フェネックス インコーポレイテッド 微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および／または質が改善されている特定の株を同定する方法
US8298789B2 (en) 2007-08-09 2012-10-30 Usv Limited Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)
DE112008002456T5 (de) * 2007-09-21 2011-01-13 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag
WO2009086132A2 (en) 2007-12-20 2009-07-09 University Of Southern California Design of spacers to increase the expression of recombinant fusion proteins
EP2127678A1 (en) 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology
JP2010006745A (ja) * 2008-06-27 2010-01-14 Sekisui Chem Co Ltd 融合タンパク質、融合タンパク質固定化担体、化合物のスクリーニング方法、スクリーニング用組成物、並びに、スクリーニング用キット
KR101387693B1 (ko) 2008-12-04 2014-04-21 한국생명공학연구원 고분비성 단백질의 스크리닝 및 재조합 단백질의 생산을 위한 융합 파트너로서 그의 용도
NZ603033A (en) 2010-04-01 2014-06-27 Pfenex Inc Methods for g-csf production in a pseudomonas host cell
WO2011151714A1 (en) 2010-06-04 2011-12-08 Lupin Limited Modified sak gene for the production of recombinant proteins
AR086250A1 (es) 2011-05-05 2013-11-27 Hoffmann La Roche Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク． ペプチド産生のための融合パートナー
US20180023098A1 (en) 2015-02-13 2018-01-25 Sekisui Chemical Co., Ltd. Nucleic acid, fusion protein, recombined cell, and isoprene or cyclic terpene production method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.-H. Ahn 등, PLoS ONE, 6(11): e26875, p.1-9 (2011.11.02.)*

Also Published As

Publication number Publication date
EP3227455A1 (en) 2017-10-11
BR112017011662A2 (pt) 2018-02-27
AU2015355242A1 (en) 2017-06-22
AU2015355242B2 (en) 2020-10-08
CN107532190B (zh) 2021-07-09
US10981968B2 (en) 2021-04-20
ES2952405T3 (es) 2023-10-31
DK3227455T3 (da) 2023-08-21
CN107532190A (zh) 2018-01-02
KR20170085129A (ko) 2017-07-21
JP2017536835A (ja) 2017-12-14
TW201629226A (zh) 2016-08-16
RU2017123283A (ru) 2019-01-09
TWI702289B (zh) 2020-08-21
CN113444183B (zh) 2025-06-17
CA2966358C (en) 2021-12-07
JP2021003117A (ja) 2021-01-14
MX2017006866A (es) 2017-11-15
JP6817939B2 (ja) 2021-01-20
JP7148579B2 (ja) 2022-10-05
HK1245336A1 (en) 2018-08-24
MX386884B (es) 2025-03-19
CA2966358A1 (en) 2016-06-09
US10118956B2 (en) 2018-11-06
EP3227455B1 (en) 2023-07-12
AR102865A1 (es) 2017-03-29
EP3227455A4 (en) 2018-07-04
CN113444183A (zh) 2021-09-28
WO2016089782A1 (en) 2016-06-09
NZ732400A (en) 2021-07-30
US20190135889A1 (en) 2019-05-09
SG11201704362VA (en) 2017-06-29
US20160159877A1 (en) 2016-06-09

Similar Documents

Publication Publication Date Title
KR102353262B1 (ko) 펩티드 생산용 융합 파트너
CN102239183B (zh) 大量分泌的蛋白的筛选和它们作为融合配偶体在重组蛋白制备中应用
CN111278852B (zh) 重组欧氏杆菌天冬酰胺酶的生产方法
CN111278979B (zh) 重组大肠杆菌天冬酰胺酶的生产方法
KR101739128B1 (ko) 재조합 ｃｒｍ197의 고 수준 발현
MXPA06005705A (es) Sistemas de expresion mejorada con secrecion de sistema de sec.
JP2012165748A (ja) 組み換えタンパク質生産用タンパク質融合因子ライブラリーおよびこれから獲得されたタンパク質融合因子
KR101183720B1 (ko) 슈도모나스 플루오레센스에서의 포유류 단백질의 발현
EP3289088B1 (en) Uncoupling growth and protein production
EP1713930B1 (en) Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom
KR20200073280A (ko) 주변세포질 단백질 발현을 위한 박테리아 리더 서열
EP3904520A1 (en) Gene expression cassette for expressing n-terminal methionine-truncated protein of interest and method for producing n-terminal methionine-truncated protein of interest by using same
HK1245336B (en) Fusion partners for peptide production
BR112017011662B1 (pt) Parceiros de fusão para a produção de peptídeo
HK40009188A (en) Signal polypeptide for improved secretion of protein
MXPA06008061A (en) Expression of mammalian proteins in pseudomonas fluorescens

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170620

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201111

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20201111

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210310

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210827

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210310

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20210827

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210610

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20201111

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20211125

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20211029

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20210827

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20210610

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20201111

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220114

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220114

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20241226

Start annual number: 4

End annual number: 4